Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Macitentan: a dual endothelin-receptor antagonist
Macitentan is an orally active, non-peptide, potent dual ERA and macitentan selectively inhibits the binding of endothelin-1 (ET-1) to ETA and ETB receptors.
Mar 24,2025 APIJAK inhibitor Upadacitinib:FDA approval,Brand name,Indications and Side effects
Upadacitinib received FDA approval on August 16, 2019, based on positive and promising results from its multinational phase III trials in subjects with moderate to severe rheumatoid arthritis.
Mar 24,2025 APISelpercatinib (LOXO-292):Indications, Mechnaism,Clinical trials and Side effects
Selpercatinib (LOXO-292) is a highly selective RET inhibitor with activity across known oncogenic RET fusions and mutations.
Mar 21,2025 APIFruquintinib:Indications,Trials and Side effects
Fruquintinib, as an oral tyrosine kinase inhibitor (TKI), effectively suppresses vascular endothelial growth factor/vascular endothelial growth factor receptor (VEGF/VEGFR) signaling and inhibits cell
Mar 21,2025 APIPirfenidone: From Synthesis to Its Role in Treating IPF
Pirfenidone is an orally available pyridinone derivative that inhibits collagen formation and is used to treat idiopathic pulmonary fibrosis.
Mar 21,2025 APIFlunixin meglumine: An efficient and cost-effective drug
Flunixin meglumine is a potent, non-narcotic, nonsteroidal, analgesic agent with anti-inflammatory and antipyretic activity.
Mar 21,2025 API(±)-Equol: Structure, Benefits and Side Effects
?(±)-Equol is an isoflavone metabolite formed from daidzein/daidzein by bacteria in the small intestine and distal colonic regions.
Mar 20,2025 APIThe Use of Omarigliptin for the Treatment of Type 2 Diabetes
Omarigliptin is a potent, selective, oral dipeptidyl peptidase 4 (DPP4) inhibitor. Inflammation or insulin resistance might be pathological mediators of cardiovascular events in patients with type 2 d
Mar 20,2025 APIBenefits and side effects of nervonic acid levels on the human body
Nervonic acid is a monounsaturated very long-chain fatty acid (VLCFA) that is mainly found in animal brain white matter and is found in higher levels in human liver and kidney.
Mar 20,2025 APIFluoxetine hydrochloride: an FDA-approved medication
Fluoxetine hydrochloride is an FDA-approved medication that has demonstrated efficacy in treating a spectrum of psychological conditions.
Mar 19,2025 API